Lyme: Fight Harder For Science and End This War

I just had a flashback. When I was diagnosed with Lyme, I knew little about it. I went to the first infectious disease doctor with my bullseye still present, asking lots of questions. Among them, are you sure this three weeks of doxycycline is enough. He smiled, and with his eyes fixed on his computer, he said, "Yes, it's more than enough. In fact, I could just tell you to take ten days but then you'd come back later if anything went haywire and ask why I didn't give you twenty-one." He looked up, "Call me if anything goes crazy." A month later, I called. I woke up with a very sore throat and fever two days before my brother's wedding and a gland in my neck that felt like a pulsating grape. It was movable but scarily large. He said if it didn't go down in a few weeks, to let him know. It didn't, so I called again. He thought I should have it biopsied. I thought I should go see my ear, nose and throat doctor instead, who sent me for an ultrasound but felt it was a remnant of Lyme. The radiologist said it was big, but symmetrical, and not particularly alarming. He also found a few more and said to have my neck rescanned in three months. I want to point out that this symptom is extremely typical of a Lyme co-infection called Bartonella, which of course, I did not know at the time. Is that what the ID doc meant when he said to reach out if anything went crazy? He seemed more than willing to have me get a biopsy of a lymph node that sits on top of my carotid a...
Source: Science - The Huffington Post - Category: Science Source Type: news

Related Links:

Source: Journal of Neurology - Category: Neurology Source Type: research
ConclusionOur study showed that CUSUM can be used to assess competence in USG-PIV procedures performed by pediatric anesthesia fellows and to identify learners not progressing toward competency in procedural skills. Ultrasound-guided venous access required more attempts to achieve competency in younger patients.
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research
Oncogene, Published online: 22 January 2022; doi:10.1038/s41388-021-02150-4Role of Nischarin in the pathology of diseases: a special emphasis on breast cancer
Source: Oncogene - Category: Cancer & Oncology Authors: Source Type: research
AbstractThis prospective cohort enrolled all patients above 16  years of age presenting to the in the emergency department (ED) for a reported syncope was designed to test the accuracy of a point-of-care ultrasound (POCUS) integrated approach in risk stratification. The emergency physician responsible for the patient care was asked to classify the syncope risk after the initial clinical assessment and after performing POCUS evaluation. All risk group definitions were based on the 2018 European Society of Cardiology guidelines. Thirty days after the index event, all participants were followed up to assess the frequency...
Source: Internal and Emergency Medicine - Category: Emergency Medicine Source Type: research
ConclusionGenerally, our study established the gut microbiome-based signature for liver cancer prediction and screening and revealed that gut microbiome characteristic in primary liver cancer was correlated with adverse inflammatory response markers in liver cancer.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
ConclusionOur data emphasize that metabolic dysfunction has a significant impact on hepatocarcinogenesis in patients with NAFLD. Moreover, coexisting multiple metabolic risk factors would dampen the risk of developing HCC in patients with NAFLD. Closely tracing HCC formation through laboratory examination or imaging is crucial in these patients.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
ConclusionaVNS ameliorates gastric motility and improves the mental state in the FD-like rat, probably via inhibiting the CRF pathway.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
Gilead never completed studies to confirm the drug's safety and efficacy, saying competition against another Bay Area-developed drug and others made doing so difficult.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
Gilead never completed studies to confirm the drug's safety and efficacy, saying competition against another Bay Area-developed drug and others made doing so difficult.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Children | Computers | Depression | Doxycycline | ENT & OMF | Eyes | Heart | Heart Failure | Hospitals | Infectious Diseases | Lyme Disease | Papanicolaou (Pap) Smear | Parasitic Diseases | Parasitology | Politics | Radiology | Science | Sore Throat | Suicide | Ultrasound | Websites